| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/29/1998 | US5814464 Nucleic acids encoding TIE-2 ligand-2 |
| 09/29/1998 | US5814441 HTLV-I and HTLV-II peptide antigens and methods |
| 09/29/1998 | US5814347 Blocking viral dna replication, absorption and extrusion of silica for infections |
| 09/29/1998 | US5814319 Solutions of water with plant extracts of aspalathus with carriers |
| 09/29/1998 | US5814305 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions |
| 09/29/1998 | CA2118032C Therapeutic conjugates of toxins and drugs |
| 09/29/1998 | CA1340063C Production of animal lysozyme c via secretion from pichia pastoris and composition therefor |
| 09/27/1998 | CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10 |
| 09/24/1998 | WO1998041562A1 Non-antigenic branched polymer conjugates |
| 09/24/1998 | WO1998041242A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
| 09/24/1998 | WO1998041218A1 An aqueous metal bicarbonate solution and method of use |
| 09/24/1998 | WO1998041207A1 Administration of an injectable antibiotic in the ear of an animal |
| 09/24/1998 | WO1998041196A1 Antiviral agents |
| 09/24/1998 | DE19713434C1 Protein zur Inhibierung von Apoptose Protein for the inhibition of apoptosis |
| 09/24/1998 | CA2285988A1 Antiviral agents |
| 09/24/1998 | CA2277179A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
| 09/23/1998 | EP0866126A1 CDNA clone HNFDY20 that encodes a novel human 7-transmembrane receptor |
| 09/23/1998 | EP0865491A1 Compounds having lectin properties and biological uses thereof |
| 09/23/1998 | EP0865447A1 Cyclic dodecapeptide and process for the preparation thereof |
| 09/23/1998 | EP0865296A1 Influenza vaccine |
| 09/23/1998 | EP0865293A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/23/1998 | EP0865283A1 2-deoxystreptamine as a molecular scaffold for preparing functionally and spacially diverse molecules and pharmaceutical compositions thereof |
| 09/23/1998 | EP0865279A1 Hemoregulatory compounds |
| 09/23/1998 | EP0865278A1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 09/23/1998 | EP0865277A1 Use of fungicidal agents for selective decontamination of teeth and dental prostheses |
| 09/23/1998 | EP0714393B1 Thiazoles as antiviral |
| 09/23/1998 | EP0693077B1 Antiviral compounds |
| 09/23/1998 | CN1194005A Method for producing influenza hemagglutinin multivalent vaccines |
| 09/23/1998 | CN1194001A Neutralizing conformational epitopes of chicken anemia virus |
| 09/23/1998 | CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 09/23/1998 | CN1193977A Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin |
| 09/23/1998 | CN1193961A Substituted benzylaminopiperidine compounds |
| 09/23/1998 | CN1193912A Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral |
| 09/22/1998 | US5811576 1-carboxy-2-loweralkyl-3,4,6-tri(halo)benzenes; grampositive and-negative bacteria; infections; sterilization of medical equipment |
| 09/22/1998 | US5811568 Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity |
| 09/22/1998 | US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis |
| 09/22/1998 | US5811549 Process of preparing imidazole compounds |
| 09/22/1998 | US5811537 Antisense oligonucleotides targeted against human immunodeficiency virus |
| 09/22/1998 | US5811534 Purine-based compounds for inclusion into oligonucleotides |
| 09/22/1998 | US5811524 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 09/22/1998 | US5811464 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, virus or protozoan infections as well as for immunomodulation |
| 09/22/1998 | US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders |
| 09/22/1998 | US5811426 Urea and thiourea derivatives of azolones |
| 09/22/1998 | US5811422 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 09/22/1998 | US5811419 Isooxacephem-derivatives |
| 09/22/1998 | US5811409 Treatment of cholera |
| 09/22/1998 | US5811407 Using alphaviruses as vectors containing immunogenic or therapeutic proteins; |
| 09/22/1998 | US5811275 HIV-specific ribozymes |
| 09/22/1998 | US5811249 Control of infectious microorganisms by modulation of chorionic gonadotropin-related protein activity |
| 09/22/1998 | US5811237 Sequence coding for protein expressed by campylobacter pylori |
| 09/22/1998 | US5811234 Methods and applications for efficient genetic suppressor elements |
| 09/22/1998 | US5811130 Danofloxacin, magnesium compound. zinc compound, antioxidant,co-solvent |
| 09/22/1998 | US5811103 An isolated dna ssequence encoding the ff/f8 kd protein of hcv; recombinant mucleic acid of a vector and the dna sequence; cell cultures |
| 09/22/1998 | US5811102 Modified meningococcal polysaccharide conjugate vaccines |
| 09/22/1998 | US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling |
| 09/22/1998 | CA2056911C Hiv protease inhibitors |
| 09/22/1998 | CA2054471C Aminoglycoside composition having substantially reduced nephrotoxicity induced by the amino glycoside |
| 09/19/1998 | CA2224128A1 Cdna clone hnfdy20 that encodes a novel human 7-transmembrane receptor |
| 09/17/1998 | WO1998040507A1 Expression of a modified foamy virus envelope protein |
| 09/17/1998 | WO1998040493A1 Fiv vaccine |
| 09/17/1998 | WO1998040483A2 28 human secreted proteins |
| 09/17/1998 | WO1998040410A1 Polyvalent carbohydrate molecules |
| 09/17/1998 | WO1998040401A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | WO1998040393A1 Novel mycaminosyltylonolide derivatives |
| 09/17/1998 | WO1998040381A1 Inhibitors of impdh enzyme |
| 09/17/1998 | WO1998040373A1 Ring opening metathesis of alkenes |
| 09/17/1998 | WO1998040357A2 Hiv protease inhibitors |
| 09/17/1998 | WO1998040350A1 Salicylic acid-sphingoid base derivatives and uses thereof |
| 09/17/1998 | WO1998040100A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT |
| 09/17/1998 | WO1998040099A1 Leptospira pathogens |
| 09/17/1998 | WO1998040094A1 Hydrophilic binary systems for the administration of cyclosporine |
| 09/17/1998 | WO1998040058A2 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides |
| 09/17/1998 | WO1998040057A1 Spermicide |
| 09/17/1998 | WO1998040056A2 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 09/17/1998 | WO1998040054A1 An enteric coated oral dosage form comprising sodium amoxycillin |
| 09/17/1998 | WO1998032467A3 Method and conjugate for treating h. pylori infection |
| 09/17/1998 | WO1998030683A3 Nuclear transfer with differentiated fetal and adult donor cells |
| 09/17/1998 | WO1998030242A3 Photochemotherapeutic compositions |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | DE19706489A1 Verwendung von 2-Desoxyglucose zur Suppression viraler Transkription Using 2-deoxyglucose for suppression of viral transcription |
| 09/17/1998 | CA2285446A1 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 09/17/1998 | CA2284163A1 Hiv protease inhibitors |
| 09/17/1998 | CA2283678A1 28 human secreted proteins |
| 09/17/1998 | CA2283624A1 Leptospira pathogens |
| 09/17/1998 | CA2283557A1 Use of nucleic acids containing unmethylated cpg dinucleotide as an adjuvant |
| 09/17/1998 | CA2283490A1 Fiv vaccine |
| 09/17/1998 | CA2283485A1 Spermicide |
| 09/17/1998 | CA2283182A1 Ring opening metathesis of alkenes |
| 09/17/1998 | CA2282807A1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | CA2282398A1 Inhibitors of impdh enzyme |
| 09/16/1998 | EP0864649A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
| 09/16/1998 | EP0864646A2 Process for the inactivation of enveloped viruses |
| 09/16/1998 | EP0864584A1 Lipopetide from Actinoplanes sp. with pharmacological properties, process for its preparation and its use |
| 09/16/1998 | EP0864579A2 Bismuth salts of moenomycin-like antibiotics, preparation, use and pharmaceuticals containing such salts |
| 09/16/1998 | EP0863986A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 09/16/1998 | EP0863981A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 09/16/1998 | EP0863903A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 09/16/1998 | EP0863901A1 Carbapenem antibiotic, composition and method of preparation |
| 09/16/1998 | EP0863890A1 5-amidomethyl alpha, betha-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents |
| 09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |